Table 1 Clinicopathologic features of the patients
Age, y, median (range) | 53 (10 ~ 70) |
Gender (male/female) | 290/52 |
Hepatitis infection (no/yes) | 94/248 |
Liver cirrhosis (no/yes) | 38/304 |
AFP, ng/ml, median (range) | 98.5 (0 ~ 60500) |
γ-GT, U/L, median (range) | 57 (7 ~ 693) |
ALT, U/L, median (range) | 39 (8 ~ 949) |
Child-Pugh score (A/B) | 342/0 |
Tumor size, cm, median (range) | 4 (1.0 ~ 21.0) |
Tumor number (single/multiple) | 298/44 |
Tumor capsule (yes/no) | 183/159 |
Tumor differentiation (I/II/III/IV) | 7/248/85/2 |
Tumor thrombi (no/yes) | 249/93 |
TNM stage (I/II&III) | 154/188 |
BCLC stage (A/B&C) | 233/109 |
Prophylactic therapy (none/TACE/immunotherapya) | 342/0/0 |
Post-recurrence therapy (none/TACE/regionalb/resection/othersc) | 221/121/0/0 |